456 related articles for article (PubMed ID: 30877215)
1. Clinical Outcomes and Clinico-pathological Correlations in Lupus Nephritis with Kidney Biopsy Showing Thrombotic Microangiopathy.
Li C; Yap DYH; Chan G; Wen YB; Li H; Tang C; Li XM; Li XW; Chan TM
J Rheumatol; 2019 Nov; 46(11):1478-1484. PubMed ID: 30877215
[TBL] [Abstract][Full Text] [Related]
2. Renal thrombotic microangiopathy associated to worse renal prognosis in Lupus Nephritis.
Strufaldi FL; Menezes Neves PDMM; Dias CB; Yu L; Woronik V; Cavalcante LB; Malheiros DMAC; Jorge LB
J Nephrol; 2021 Aug; 34(4):1147-1156. PubMed ID: 33570723
[TBL] [Abstract][Full Text] [Related]
3. Renal Thrombotic Microangiopathy in Proliferative Lupus Nephritis: Risk Factors and Clinical Outcomes: A Case-Control Study.
Barrera-Vargas A; Rosado-Canto R; Merayo-Chalico J; Arreola-Guerra JM; Mejía-Vilet JM; Correa-Rotter R; Gómez-Martín D; Alcocer-Varela J
J Clin Rheumatol; 2016 Aug; 22(5):235-40. PubMed ID: 27464767
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological features and outcomes of SLE patients with renal injury characterised by thrombotic microangiopathy.
Chen W; Liang S; Zuo K; Yang L; Zeng C; Hu W
Clin Rheumatol; 2021 Jul; 40(7):2735-2743. PubMed ID: 33543375
[TBL] [Abstract][Full Text] [Related]
5. Clinical Characteristics and Prognosis of Renal Thrombotic Microangiopathy in Lupus Nephritis.
Chen X; Cheng W; Wang G; Qi Y; Xiao J; Wang X; Zhao Z
Iran J Kidney Dis; 2021 May; 15(3):169-176. PubMed ID: 33994376
[TBL] [Abstract][Full Text] [Related]
6. Kidney thrombotic microangiopathy in lupus nephritis: Impact on treatment and prognosis.
Massicotte-Azarniouch D; Kotzen E; Todd S; Hu Y; Hogan SL; Jain K
Lupus; 2022 Sep; 31(10):1175-1185. PubMed ID: 35650019
[TBL] [Abstract][Full Text] [Related]
7. The spectrum of renal thrombotic microangiopathy in lupus nephritis.
Song D; Wu LH; Wang FM; Yang XW; Zhu D; Chen M; Yu F; Liu G; Zhao MH
Arthritis Res Ther; 2013 Jan; 15(1):R12. PubMed ID: 23320601
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic microangiopathy in systemic lupus erythematosus: efficacy of eculizumab.
El-Husseini A; Hannan S; Awad A; Jennings S; Cornea V; Sawaya BP
Am J Kidney Dis; 2015 Jan; 65(1):127-30. PubMed ID: 25446020
[TBL] [Abstract][Full Text] [Related]
9. [Clinical characteristics and prognosis of 12 cases of lupus nephritis complicated with thrombotic microangiopathy].
Cheng XQ; Zhao F; Ding GX; Zhao SL; Chen QX; Zhu CH
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Nov; 25(11):1118-1123. PubMed ID: 37990455
[TBL] [Abstract][Full Text] [Related]
10. Association of thrombotic microangiopathy and intimal hyperplasia with bleeding post-renal biopsy in antiphospholipid antibody-positive patients.
Jordan N; Chaib A; Sangle S; Tungekar F; Sabharwal T; Abbs I; Khamashta M; D'Cruz D
Arthritis Care Res (Hoboken); 2014 May; 66(5):725-31. PubMed ID: 24127353
[TBL] [Abstract][Full Text] [Related]
11. Clinico-Histological Features of Thrombotic Microangiopathy in Renal Biopsies: A Retrospective Study.
Manickam N; Agrawal V; Prasad P; Jain M; Prasad N
Turk Patoloji Derg; 2022; 38(1):1-8. PubMed ID: 34514568
[TBL] [Abstract][Full Text] [Related]
12. Plasmapheresis Is Associated With Better Renal Outcomes in Lupus Nephritis Patients With Thrombotic Microangiopathy: A Case Series Study.
Li QY; Yu F; Zhou FD; Zhao MH
Medicine (Baltimore); 2016 May; 95(18):e3595. PubMed ID: 27149490
[TBL] [Abstract][Full Text] [Related]
13. Thrombotic microangiopathy versus class IV lupus nephritis in systemic lupus erythematosus.
Alkhatib MH; Kant S; Menez S; Lakhani L; Sperati CJ; Fine DM; Arend LJ; Atta MG
J Nephrol; 2021 Dec; 34(6):1907-1913. PubMed ID: 33689148
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of clinical outcomes and renal vascular pathology among patients with lupus.
Barber C; Herzenberg A; Aghdassi E; Su J; Lou W; Qian G; Yip J; Nasr SH; Thomas D; Scholey JW; Wither J; Urowitz M; Gladman D; Reich H; Fortin PR
Clin J Am Soc Nephrol; 2012 May; 7(5):757-64. PubMed ID: 22442181
[TBL] [Abstract][Full Text] [Related]
15. A Rare Case of Lupus Nephritis Presenting as Thrombotic Microangiopathy with Diffuse Pseudotubulization Possibly Caused by Atypical Hemolytic Uremic Syndrome.
Ono M; Ohashi N; Namikawa A; Katahashi N; Ishigaki S; Tsuji N; Isobe S; Iwakura T; Sakao Y; Tsuji T; Kato A; Fujigaki Y; Shimizu A; Yasuda H
Intern Med; 2018 Jun; 57(11):1617-1623. PubMed ID: 29434134
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of renal vascular pathology in lupus nephritis.
Mejía-Vilet JM; Córdova-Sánchez BM; Uribe-Uribe NO; Correa-Rotter R; Morales-Buenrostro LE
Lupus; 2017 Sep; 26(10):1042-1050. PubMed ID: 28178879
[TBL] [Abstract][Full Text] [Related]
17. Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis.
Mejia-Vilet JM; Gómez-Ruiz IA; Cruz C; Méndez-Pérez RA; Comunidad-Bonilla RA; Uribe-Uribe NO; Nuñez-Alvarez CA; Morales-Buenrostro LE
Clin Rheumatol; 2021 Jun; 40(6):2233-2242. PubMed ID: 33170371
[TBL] [Abstract][Full Text] [Related]
18. Lupus nephritis combined with renal injury due to thrombotic thrombocytopaenic purpura-haemolytic uraemic syndrome.
Yu F; Tan Y; Zhao MH
Nephrol Dial Transplant; 2010 Jan; 25(1):145-52. PubMed ID: 19703836
[TBL] [Abstract][Full Text] [Related]
19. Thrombotic microangiopathy and poor renal outcome in lupus patients with or without antiphospholipid syndrome.
Hernandez-Molina G; García-Trejo LP; Uribe N; Cabral AR
Clin Exp Rheumatol; 2015; 33(4):503-8. PubMed ID: 26203932
[TBL] [Abstract][Full Text] [Related]
20. [Eculizumab as rescue therapy for lupus nephritis-related thrombotic microangiopathy].
Fani FM; Patera A; Delsante M; Rossi GM; Manenti L; Landini S; Regolisti G; Fiaccadori E
G Ital Nefrol; 2020 Jun; 37(3):. PubMed ID: 32530153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
